33
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T10160 |
11β-HSD1-IN-1
|
Dehydrogenase | Metabolism |
11β-HSD1-IN-1是1β 羟类固醇脱氢酶Ⅰ型(11β-HSD1,IC50:52nM)的抑制剂,用于治疗疼痛。 | |||
T64321 |
Octyl-beta-D-glucopyranoside
Octyl glucoside,11β-HSD1-IN-11 |
Others | Others |
Octyl-beta-D-glucopyranoside (11β-HSD1-IN-11) 是一种非离子洗涤剂,广泛应用于生物技术,生化应用,膜蛋白的增溶和结晶的研究中。 | |||
T72814 |
11β-HSD1-IN-12
|
Dehydrogenase | Metabolism |
11β-HSD1-IN-12 是一种11β-HSD1抑制剂。11β-HSD1 可从非活性形式再生活性糖皮质激素,在调节细胞内糖皮质激素浓度方面很重要。11β-HSD1-IN-12 可用于肥胖和代谢综合征的研究。 | |||
T67903 |
11β-HSD1 inibitor 17
|
Dehydrogenase | Metabolism |
11β-HSD1 inibitor 17 是11β-羟基类固醇脱氢酶(11β-HSD1)抑制剂。 | |||
T72022 |
11β-HSD1 inibitor 19
|
||
11β-HSD1 inibitor 19 对 hHSD1 和 mHSD1 显示抑制活性,IC50 为 16 nM 和 10 nM。 | |||
T60149 |
11β-HSD1-IN-11
|
Dehydrogenase | Metabolism |
11β-HSD1-IN-11 是一种有效的、具有竞争性的 11- β-羟基类固醇脱氢酶1 (11β-HSD1)抑制剂,对大鼠和人的 11β-HSD1具有抑制作用,IC50 分别为 0.34 μM 和 0.13 μM。11β-HSD1- in -11是一种作为的化合物。11β-HSD1-IN-11是一种参与调节各种生理过程的激素,例如代谢、炎症和应激反应。11β-HSD1-IN-11是治疗代谢紊乱、肥胖和某些炎症状况的潜在化合物。 | |||
T65743 |
11β-HSD1-IN-8
|
||
11β-HSD1-IN-8 是一种有用的有机化合物,可用于生命科学领域的相关研究。其产品编号为 T65743,CAS号为 386704-15-0。 | |||
T72911 | 11β-HSD1-IN-9 | ||
11β-HSD1-IN-9 (化合物 c4a) 是有效对人源和鼠源11β-HSD1的抑制剂,其 IC50 值分别为 0.48 µM 和 1.3 µM。此化合物与大鼠11β-HSD1之间存在竞争性相互作用,适用于研究肥胖、高血糖和认知障碍。 | |||
T72859 |
11β-HSD1-IN-10
|
||
11β-HSD1-IN-10 (化合物 c3a) 是一种针对11β-HSD1的有效抑制剂,具有对人IC50值为1.8 µM。可应用于肥胖、高血糖和认知障碍研究。 | |||
T61593 | 11β-HSD1-IN-6 | ||
11β-HSD1-IN-6 is a potent inhibitor of 11β hydroxysteroid dehydrogenase enzymes (11β-HSDs). These enzymes are responsible for catalyzing the conversion of the active glucocorticoids, corticosterone or cortisol, to their respective inactive forms, 11-dehydrocorticosterone (11-DHC) and cortisone. The compound 11β-HSD1-IN-6 specifically targets and inhibits 11β-HSD-1, effectively modulating the interconversion of these glucocorticoids. [1] | |||
T67622 | 11β-HSD1-IN-7 | ||
11β-HSD1-IN-7 是一种有用的有机化合物,可用于生命科学领域的相关研究。其产品编号为 T67622,CAS号为 728-86-9。 | |||
T3542 |
BVT-14225
BVT 14225 |
Dehydrogenase | Metabolism |
BVT-14225 是一种选择性的11β羟基类固醇脱氢酶1型(11β-HSD1)抑制剂(IC50:52 nM)。 | |||
T14388 |
AZD 4017
|
Dehydrogenase | Metabolism |
AZD 4017 是高效的、选择性的11β-HSD1抑制剂,IC50为 7 nM。 | |||
T2057 |
BVT 2733
|
Dehydrogenase | Metabolism |
BVT 2733 是具有口服活性的、强效的、非甾体类11β-HSD1选择性抑制剂。它对小鼠 11β-HSD1 酶的作用 (IC50:96 nM) 比对人 11β-HSD1 酶 (IC50:3341 nM) 的作用强。它对关节炎和肥胖相关疾病具有潜在的研究价值。 | |||
T63569 |
HSD-016
|
||
HSD-016 是选择性的、有效的、口服具有活力的 1 型 11β-羟类固醇脱氢酶(11β-HSD1)抑制剂,能够作用于人 11β-HSD1 (IC50: 11 nM)、小鼠 11β-HSD1 (IC50: 1 nM)、大鼠 11β-HSD1 (IC50: 8 nM)。HSD-016 能够用于研究 2 型糖尿病。 | |||
T77606 |
WAY-311610
|
Dehydrogenase | Metabolism |
WAY-311610是一种11β-羟基类固醇脱氢酶HSD11B1抑制剂,抑制11β-HSD1酶,IC = 0.34μM。可用于研究神经性疼痛、炎症性疼痛和枕神经痛。 | |||
T64349 |
Necroptosis-IN-3
Cyclohexanecarboxamide, N-(2-thienylmethyl)- |
Necroptosis | Apoptosis |
Necroptosis-IN-3 (Cyclohexanecarboxamide, N-(2-thienylmethyl)-)(Compound 69) 是一种坏死性凋亡 (necroptosis) 抑制剂,抑制 TNF-α 诱导的坏死性凋亡。Necroptosis-IN-3(Compound 69) 也抑制 11β-HSD1。 | |||
T14383 |
AZD8329
|
Dehydrogenase | Metabolism |
AZD8329 是一种可选择且高效的人重组11β-HSD1 和离体人脂肪细胞11ß-HSD1 的抑制剂,是大鼠11β-HSD1 (IC50 - 89nM)和狗重组11β-HSD1的抑制剂。AZD8329在体外实验中对11β-HSD1的亲和力高于人重组11β-HSD2和17β- hsd1和17β-HSD3酶。AZD8329具有降低脂肪组织和肝脏样品中11β-HSD1的活性。 | |||
T16510 |
PF-915275
|
Dehydrogenase | Metabolism |
PF-915275 是口服有效的人 11β-羟基类固醇脱氢酶1型选择性抑制剂,Ki 为 2.3 nM,在 HEK293 细胞中的EC50为 15 nM 。它对人和猴原代肝细胞中可的松向皮质醇的转化具有剂量依赖性,EC50分别为 20 nM 和 100 nM。 | |||
T26794 |
BI-135585
|
||
BI-135585 is a potent and selective inhibitor of 11β-HSD1. | |||
T12663 | (Rac)-BMS-816336 | Dehydrogenase | Metabolism |
(Rac)-BMS-816336 (Compound 6n) 是 BMS-816336 的外消旋体。(Rac)-BMS-816336 是人和小鼠 11β-羟类固醇脱氢酶 1 型 (11β-HSD1) 的有效抑制剂,其 IC50分别为 10 nM 和 68 nM,并具有良好的代谢稳定性 。 | |||
T0293 |
Metyrapone
美替拉酮,甲吡酮,NSC-25265,Su-4885 |
Others; P450; Dehydrogenase; Autophagy | Autophagy; Metabolism; Others |
Metyrapone (NSC-25265) 是 STEROID 11-BETA-MONOOXYGENASE 酶抑制剂。 它被用作库欣综合征诊断中下丘脑-垂体反馈机制的测试。 | |||
T23845 |
BVT-116429
|
||
BVT-116429 is an inhibitor of 11β-HSD1. | |||
T60203 |
INCB13739
|
||
INCB13739是一种具有口服活性、高效、选择性及组织特异性的11β-HSD1抑制剂,对11β-HSD1酶的IC50为3.2 nM,对11β-HSD1 PBMC的IC50为1.1 nM。适用于2型糖尿病(T2DM)和肥胖的研究。 | |||
T26617 |
AMG-221
AMG221 |
||
AMG-221 is a potent and selective 11β-HSD1 inhibitor. AMG-221 decreased fed blood glucose and insulin levels and reduced body weight in diet-induced obesity mice. | |||
T28796 |
SKI2852
SK I2852,SKI-2852 |
||
SKI2852 is a highly Potent, selective, and orally bioavailable inhibitor of 11β-Hydroxysteroid Dehydrogenase Type 1 (11β-HSD1). hHSD1 IC50 = 2.9nM; mHSD1 IC50 = 1.6nM. | |||
T26724 |
AZD-9164 bromide
AZD9164,AZD-9164,AZD 9164 |
||
AMG-221 is a potent and selective 11β-HSD1 inhibitor. AMG 221 potently blocked 11β-HSD1 activity, producing sustained inhibition for the 24-hour study duration as measured in ex vivo adipose samples. AMG-221 decreased fed blood glucose and insulin levels | |||
T71243 | ASP3662 | ||
ASP3662, also known as SPI-62, is a potent, selective and CNS-penetrable inhibitor of 11β-HSD1. The effects of ASP3662 suggest that selective inhibition of 11β-HSD1 may be an attractive approach for the treatment of neuropathic and dysfunctional pain, as observed in fibromyalgia. ASP3662 inhibited human, mouse and rat 11β-HSD1 but not human 11β-HSD2, in vitro. ASP3662 inhibited in vitro conversion of glucocorticoid from its inactive to active form in extracts of rat brain and spinal cord. | |||
T72249 |
BMS-823778 hydrochloride
|
||
BMS-823778 hydrochloride为一种高效、选择性的口服11β-HSD1抑制剂,其对人11β-HSD1的IC50值为2.3 nM。 | |||
T80817 |
WAY-328127
|
||
WAY-328127是一种活性分子,适用于生化反应研究。 | |||
T70509 |
INU-101
|
||
INU-101 is an 11β-HSD1 inhibitor. In KKAy mice, ob/ob mice, and ZDF rats, oral administration of INU-101 led to enhanced insulin sensitivity and the lowering of the fasting level of glucose in the blood. INU-101 therefore shows promise as a potential treatment for type 2 diabetes and metabolic syndrome. | |||
T70763 |
KR-67607
|
||
KR-67607, also known as NTX-101 is novel selective 11β-hydroxysteroid dehydrogenase 1 (11β-HSD1) inhibitor. KR-67607 decreased 4-hydroxynonenal expression and increased antioxidant and mucus secretion in BAC-treated rat eyes. KR-67607 showed its protective effects against ischemia-reperfusion-induced eye injury. KR-67607 effectively reduced cortisol levels in mouse eyes and maintained the trabecular meshwork (TM) structure in the presence of transient ischemic stress. Furthermore, KR-67607 rever... | |||
T26528 |
ABT-384
|
||
ABT-384 is an inhibitor of 11β-hydroxysteroid dehydrogenase type 1. |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T2869 |
Emodin
Frangula emodin,大黄素 |
SARS-CoV; Casein Kinase; Autophagy | Autophagy; Metabolism; Microbiology/Virology; Stem Cells |
Emodin (Frangula emodin) 是蒽醌衍生物,有抗SARS-CoV 作用。它阻断 SARS 冠状病毒刺突蛋白和血管紧张素转化酶 2 的相互作用。它抑制酪蛋白激酶 2 ,具有抗炎和抗癌作用。它可改善饮食诱导的肥胖小鼠的代谢紊乱。 |